Medical Eligibility Required Semaglutide cannot be prescribed to individuals with the following conditions: BMI under 27, eating disorders, Type 1 diabetes, gallbladder disease, substance abuse, recent bariatric surgery (within the past 6 months), pancreatitis or history of recurrent pancreatitis while taking a GLP-1 medication, medullary thyroid cancer, current pregnancy or breastfeeding, plans to become pregnant, diabetic retinopathy, multiple endocrine neoplasia type 2 (MEN2) or family history of MEN2, serious gastrointestinal disorders, or history of allergic reaction to Semaglutide
Metabolomic Signatures of Autism Spectrum Disorder
No surprise membership fees hiding the real price of care
Conclusion While diarrhea can be a challenging side effect of Wegovy, understanding its causes and implementing effective management strategies can help alleviate discomfort
Sharpe (2020)
PlexusDx Approach to Personalized Semaglutide Treatment PlexusDx offers Compounded Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan, prepared by licensed 503A compounding pharmacies serving all 50 states without requiring insurance or membership fees